CUAMC
DRUG

China Universal Asset Management Company’s Bright Minds Biosciences DRUG Stock Holding History

China Universal Asset Management Company’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.1K Buy
600
+100
+20% +$7.85K ﹤0.01% 467
2026
Q1 		$36.5K Buy
+500
New +$40.2K ﹤0.01% 474

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

China Universal Asset Management Company's DRUG Position: Q2 2026 in Review

China Universal Asset Management Company increased its Bright Minds Biosciences (DRUG) stake by 20% in Q2 2026, buying an estimated $7.85K and bringing the position to 600 shares worth $42.1K. The position accounts for ﹤0.01% of the portfolio, ranked #467.

China Universal Asset Management Company first reported a position in DRUG in Q1 2026 and has held it in 2 quarters since. 100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • China Universal Asset Management Company held 600 shares of Bright Minds Biosciences worth $42.1K as of Q2 2026.
  • China Universal Asset Management Company bought 100 Bright Minds Biosciences shares in Q2 2026, an estimated $7.85K.
  • Bright Minds Biosciences made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #467 holding.
  • China Universal Asset Management Company first reported a position in Bright Minds Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.